Moussa M, Papatsoris A, Abou Chakra M, & Dellis A. (2021). Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date. Dove Medical Press.
Chicago Style (17th ed.) CitationMoussa M, Papatsoris A, Abou Chakra M, and Dellis A. Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date. Dove Medical Press, 2021.
MLA (9th ed.) CitationMoussa M, et al. Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.